Conversations on Cancer: Patient first = Project Facilitate

Join the FDA Oncology Center of Excellence for a compelling Conversation on Cancer focused on Project Facilitate, a dedicated resource designed to streamline access to investigational therapies for patients facing life-threatening cancers. When standard treatment options are exhausted and clinical trial enrollment isn't possible, FDA's Expanded Access Program offers a critical pathway for patients to access investigational drugs, biologics, or medical devices that have not yet received FDA approval. However, navigating the single-patient Investigational New Drug (IND) application process can be daunting, particularly for oncology healthcare providers without extensive regulatory experience. Project Facilitate serves as a single point of contact, offering expert guidance to help oncology professionals successfully submit expanded access requests and bring hope to their patients in urgent need.